Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 136 member D, pseudogene (FAM136DP) is classified as a **pseudogene**—a DNA segment that closely resembles a known gene family member but does not encode a functional protein. Most pseudogenes arise through gene duplication or retrotransposition events and then acquire disabling mutations. While traditionally considered “junk DNA,” recent research indicates that some pseudogenes can generate non-coding RNAs capable of regulating their parental gene’s expression or acting as miRNA sponges, potentially modulating cellular processes. There is, however, no direct evidence that FAM136DP itself has a specific functional or pathological role, and it is not considered a therapeutic or diagnostic molecular target.
None known; not a recognized drug target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 136 member D, pseudogene (FAM136DP).